Northern Trust’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Northern Trust’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,300	Closed	-$435K	–	4692
2021 Q2	$435K	Sell	6,300 -637	-9%	-$48.6K	﹤0.01%	3769
2021 Q1	$536K	Sell	6,937 -5,198	-43%	-$479K	﹤0.01%	3799
2020 Q4	$1.2M	Buy	12,135 +322	+3%	+$39.4K	﹤0.01%	3442
2020 Q3	$1.68M	Sell	11,813 -4,192	-26%	-$699K	﹤0.01%	3137
2020 Q2	$3.16M	Sell	16,005 -5,422	-25%	-$1.12M	﹤0.01%	2790
2020 Q1	$4.2M	Buy	21,427 +6,801	+46%	+$1.46M	﹤0.01%	2404
2019 Q4	$3.02M	Buy	14,626 +11,884	+433%	+$2.2M	﹤0.01%	2876
2019 Q3	$419K	Buy	+2,742	New	+$449K	﹤0.01%	3586
2017 Q3	–	Sell	-18,480	Closed	-$1.41M	–	4267
2017 Q2	$1.41M	Buy	18,480 +524	+3%	+$44.1K	﹤0.01%	3344
2017 Q1	$1.55M	Sell	17,956 -643	-3%	-$46.3K	﹤0.01%	3200
2016 Q4	$1.19M	Buy	18,599 +3,926	+27%	+$242K	﹤0.01%	3297
2016 Q3	$949K	Sell	14,673 -8,839	-38%	-$498K	﹤0.01%	3354
2016 Q2	$1.3M	Sell	23,512 -889	-4%	-$44.7K	﹤0.01%	3253
2016 Q1	$993K	Buy	+24,401	New	+$1.13M	﹤0.01%	3257

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Northern Trust's LKFT Position: Q3 2021 in Review

Northern Trust sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 6,300 shares — an estimated $435K sold.

Northern Trust first reported a position in LKFT in Q1 2016 and held it in 14 quarters. The position peaked at $4.2M in Q1 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

Northern Trust reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Northern Trust sold 6,300 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $435K.
Northern Trust first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2016 and held it in 14 quarters.
Northern Trust's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.2M in Q1 2020.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.